Evidence map›Paper›PMID 22503130›Full record

ArticleJournal of pharmaceutical and biomedical analysis2013

Thermal stability of the prototypical Mn porphyrin-based superoxide dismutase mimic and potent oxidative-stress redox modulator Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin chloride, MnTE-2-PyP(5+).

Victor H A Pinto, Dayse Carvalhoda-Silva, Jonas L M S Santos, Tin Weitner, Maria Gardênnia Fonseca, Maria Irene Yoshida, Ynara M Idemori, Ines Batinić-Haberle, Júlio S Rebouças

Abstract read
In one paragraph

Article in Journal of pharmaceutical and biomedical analysis, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Mn(III) Porphyrin MnTE-2-PyPACS infectious diseases · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Redox-Active Drug, MnTE-2-PyPOxidative medicine and cellular longevity · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Victor H A PintoDepartamento de Química, CCEN, Universidade Federal da Paraíba, João Pessoa PB 58051-900, Brazil.
Dayse Carvalhoda-Silva
Jonas L M S Santos
Tin Weitner
Maria Gardênnia Fonseca
Maria Irene Yoshida
Ynara M Idemori
Ines Batinić-Haberle
Júlio S Rebouças
Universidade Federal da Paraíba · BRUniversidade Federal de Minas Gerais · BRDuke Medical Center · US

Funding

Somatostatin analogues as countermeasures against intestinal radiation toxicityU19AI067798 · NIAID · DUKE UNIVERSITY · PI CHAO, NELSON J. · 2005 to 2024
$82.1M
NIAID NIH HHS U19 AI067798NIAID NIH HHS U19AI067798
6 · The paper itself

Abstract

Cationic Mn porphyrins are among the most potent catalytic antioxidants and/or cellular redox modulators. Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin chloride (MnTE-2-PyPCl(5)) is the Mn porphyrin most studied in vivo and has successfully rescued animal models of a variety of oxidative stress-related diseases. The stability of an authentic MnTE-2-PyPCl(5) sample was investigated hereon by thermogravimetric, derivative thermogravimetric, and differential thermal analyses (TG/DTG/DTA), under dynamic air, followed by studies at selected temperatures to evaluate the decomposition path and appropriate conditions for storage and handling of these materials. All residues were analyzed by thin-layer chromatography (TLC) and UV-vis spectroscopy. Three thermal processes were observed by TG/DTG. The first event (endothermic) corresponded to dehydration, and did not alter the MnTE-2-PyPCl(5) moiety. The second event (endothermic) corresponded to the loss of EtCl (dealkylation), which was characterized by gas chromatography-mass spectrometry. The residue at 279°C had UV-vis and TLC data consistent with those of the authentic, completely dealkylated analog, MnT-2-PyPCl. The final, multi-step event corresponded to the loss of the remaining organic matter to yield Mn(3)O(4) which was characterized by IR spectroscopy. Isothermal treatment at 188°C under static air for 3h yielded a mixture of partially dealkylated MnPs and traces of the free-base, dealkylated ligand, H(2)T-2-PyP, which reveals that dealkylation is accompanied by thermal demetallation under static air conditions. Dealkylation was not observed if the sample was heated as a solid or in aqueous solution up to ∼100°C. Whereas moderate heating changes sample composition by loss of H(2)O, the dehydrated sample is indistinguishable from the original sample upon dissolution in water, which indicates that catalytic activity (on Mn basis) remains unaltered. Evidently, dealkylation at high temperature compromises sample activity.

Indexed as

AntioxidantsBiomimetic MaterialsChromatography, Thin LayerDifferential Thermal AnalysisDrug StabilityHot TemperatureMetalloporphyrinsMolecular StructureOxidation-ReductionOxidative StressSpectrophotometry, UltravioletSuperoxide DismutaseThermogravimetryTransition TemperatureAntioxidantsmanganese (III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrinMetalloporphyrinsSuperoxide Dismutase

Identifiers

PMID22503130
PMCPMC3688467
OpenAlexW2004440729

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.